STAT PROFILE PRIME PLUS ANALYZER SYSTEM 57400

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a distributor,foreign,user faci report with the FDA on 2020-01-30 for STAT PROFILE PRIME PLUS ANALYZER SYSTEM 57400 manufactured by Nova Biomedical Corp.

Event Text Entries

[183878060] Device investigation: a dhr review was performed by the quality control engineer and included an assessment of the production, testing, and release of the analyzer. No abnormalities or concerns were observed; the dhr indicated that the released product met all specifications. The customer database was reviewed and no issues were found. Nova application specialist went onsite to perform correlation to customer's reference method. The correlation data demonstrated that the analyzer performs as intended. Local distributor representatives visited the site and reviewed both patient and qc results of the concerning day and the following days together with the hospital's point of care (poc) coordinator. All qc results were inside the qc ranges and the patient results correlated as expected to lab hematology analyzer. During series of visits, local distributor noticed that the sample handling of some operators was not ideal. Samples were not always being mixed prior to analysis and clot catchers are not always used. The root cause for high hb and hct results is determined to be improper sample handling. Lack of homogeneity of a blood sample can lead to incorrect results. Immediate mixing of the sample upon blood collection insures that the anticoagulant in the specimen container has fully dissolved with the blood, thus maintaining not only the effective anticoagulant-to-blood ratio but also providing a specimen free from any blood clots. Because blood cells naturally sediment, a prior thorough mixing of the blood in the tube is necessary to ensure accurate reading.
Patient Sequence No: 1, Text Type: N, H10


[183878061] Customer reported high hemoglobin and hematocrit patient results using nova prime plus analyzer when compared to lab reference method. No harm or inappropriate treatment was reported.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1219029-2020-00004
MDR Report Key9646478
Report SourceDISTRIBUTOR,FOREIGN,USER FACI
Date Received2020-01-30
Date of Report2020-01-30
Date of Event2020-01-01
Date Mfgr Received2020-01-07
Date Added to Maude2020-01-30
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMS MARIYA CESNULEVICIUS
Manufacturer Street200 PROSPECT ST.
Manufacturer CityWALTHAM MA 024543654
Manufacturer CountryUS
Manufacturer Postal024543654
Manufacturer Phone7816473700
Manufacturer G1NOVA BIOMEDICAL CORP.
Manufacturer Street200 PROSPECT ST.
Manufacturer CityWALTHAM MA 024543465
Manufacturer CountryUS
Manufacturer Postal Code024543465
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameSTAT PROFILE PRIME PLUS ANALYZER SYSTEM
Generic NameBLOOD GAS ANALYZER
Product CodeGKR
Date Received2020-01-30
Model Number57400
Catalog Number57400
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerNOVA BIOMEDICAL CORP
Manufacturer Address200 PROSPECT ST. WALTHAM MA 024543654 US 024543654


Patients

Patient NumberTreatmentOutcomeDate
10 2020-01-30

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.